Rafferty Asset Management
GTHX

Rafferty Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Rafferty Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-137,472
Closed -$1.72M – 1163
2022
Q3 		$1.72M Buy
+137,472
New +$1.57M 0.02% 543
2022
Q2 		– Sell
-256,500
Closed -$1.95M – 1248
2022
Q1 		$1.95M Sell
256,500
-89,624
-26% -$850K 0.01% 604
2021
Q4 		$3.53M Buy
346,124
+136,288
+65% +$1.74M 0.02% 501
2021
Q3 		$2.82M Buy
209,836
+89,181
+74% +$1.45M 0.02% 518
2021
Q2 		$2.65M Sell
120,655
-22,042
-15% -$490K 0.02% 557
2021
Q1 		$3.43M Buy
142,697
+113,946
+396% +$2.65M 0.02% 401
2020
Q4 		$517K Sell
28,751
-39,830
-58% -$595K 0.01% 679
2020
Q3 		$792K Buy
68,581
+56,675
+476% +$935K 0.01% 611
2020
Q2 		$289K Buy
+11,906
New +$197K ﹤0.01% 838
2020
Q1 		– Sell
-37,648
Closed -$995K – 834
2019
Q4 		$995K Sell
37,648
-11,557
-23% -$270K 0.02% 553
2019
Q3 		$1.12M Sell
49,205
-8,296
-14% -$262K 0.02% 512
2019
Q2 		$1.76M Buy
57,501
+1,782
+3% +$37.5K 0.03% 451
2019
Q1 		$925K Buy
+55,719
New +$1.06M 0.01% 564

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Rafferty Asset Management's GTHX Position: Q4 2022 in Review

Rafferty Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2022, closing a stake of 137,472 shares — an estimated $1.72M sold.

Rafferty Asset Management first reported a position in GTHX in Q1 2019 and held it in 13 quarters. The position peaked at $3.53M in Q4 2021. 116 funds tracked by Wall St. Rank hold GTHX as of Q4 2022.

  • Rafferty Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 137,472 G1 Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1.72M.
  • Rafferty Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Rafferty Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $3.53M in Q4 2021.
  • 116 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.